We are live on ! Find out more
HRTX icon

Heron Therapeutics
HRTX

200 hedge funds and large institutions have $1.07B invested in Heron Therapeutics in 2021 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 66 increasing their positions, 57 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

23% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 26

21% more call options, than puts

Call options by funds: $12.5M | Put options by funds: $10.4M

16% more repeat investments, than reductions

Existing positions increased: 66 | Existing positions reduced: 57

8.95% more ownership

Funds ownership: 106.46% → 115.41% (+9%)

2% more funds holding

Funds holding: 197 → 200 (+3)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

8% less capital invested

Capital invested by funds: $1.16B → $1.07B (-$87.7M)

Holders
200
Holders Change
+3
Holders Change %
+1.52%
% of All Funds
3.08%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
32
Increased
66
Reduced
57
Closed
26
Calls
$12.5M
Puts
$10.4M
Net Calls
+$2.14M
Net Calls Change
+$80K

Top Buyers

1
UOC
UBS O'Connor
Illinois
+$16.8M
2
Citadel Advisors
Citadel Advisors
Florida
+$15.8M
3
State Street
State Street
Massachusetts
+$12.3M
4
Millennium Management
Millennium Management
New York
+$10.3M
5
SCM
Suvretta Capital Management
New York
+$10.2M

Top Sellers

1
Point72 Asset Management
Point72 Asset Management
Connecticut
-$17.1M
2
Wellington Management Group
Wellington Management Group
Massachusetts
-$8.01M
3
GLA
Great Lakes Advisors
Illinois
-$7.94M
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$5.24M
5
PAM
Panagora Asset Management
Massachusetts
-$4.13M
Name Holding Trade Value Shares
Change 		Change in
Stake
Cambridge Investment Research Advisors
126
Cambridge Investment Research Advisors
Iowa
$181K +$46.4K +4,540 +30%
AIM
127
Aigen Investment Management
New York
$179K +$202K +19,818 New
Lido Advisors
128
Lido Advisors
California
$171K – – –
William Blair & Company
129
William Blair & Company
Illinois
$169K – – –
EFM
130
E Fund Management
China
$168K +$36.4K +3,562 +24%
Teacher Retirement System of Texas
131
Teacher Retirement System of Texas
Texas
$168K +$45.5K +4,460 +32%
VF
132
Virtu Financial
New York
$167K +$187K +18,306 New
DT
133
Diversified Trust
Tennessee
$166K – – –
CCB
134
Cutter & Co Brokerage
Missouri
$149K -$148K -14,510 -47%
AB
135
Amalgamated Bank
New York
$149K -$1.81K -177 -1%
LPL Financial
136
LPL Financial
California
$148K +$13.3K +1,307 +9%
Public Employees Retirement Association of Colorado
137
Public Employees Retirement Association of Colorado
Colorado
$141K – – –
GLA
138
Great Lakes Advisors
Illinois
$140K -$7.94M -777,776 -98%
PHIMC
139
Private Harbour Investment Management & Counsel
Ohio
$132K -$13.3K -1,299 -8%
Victory Capital Management
140
Victory Capital Management
Texas
$127K -$4.39K -430 -3%
SFI
141
Susquehanna Fundamental Investments
Pennsylvania
$122K -$1.19M -116,728 -90%
Envestnet Asset Management
142
Envestnet Asset Management
Illinois
$108K +$120K +11,796 New
Commonwealth Equity Services
143
Commonwealth Equity Services
Massachusetts
$105K -$199K -19,458 -63%
GC
144
Grimes & Company
Massachusetts
$105K -$16.6K -1,625 -12%
RJFSA
145
Raymond James Financial Services Advisors
Florida
$99K -$4.03K -395 -4%
Mirae Asset Global Investments
146
Mirae Asset Global Investments
South Korea
$96K +$3K +294 +3%
CW
147
CreativeOne Wealth
Kansas
$92K +$103K +10,044 New
Zurich Cantonal Bank
148
Zurich Cantonal Bank
Switzerland
$89K – – –
Group One Trading
149
Group One Trading
Illinois
$86K +$95.7K +9,377 New
Macquarie Group
150
Macquarie Group
Australia
$68K -$19.4K -1,898 -20%
4 5
6
7 8

HRTX Hedge Fund Activity: Q4 2021 in Review

200 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Heron Therapeutics (HRTX) for Q4 2021, worth a combined $1.07B — down 7.6% from $1.16B a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new HRTX positions and 26 closed out — a net gain of 6 holders — while 66 added to existing stakes and 57 trimmed.

The largest buyer was UBS O'Connor, adding an estimated $16.8M. The largest seller was Point72 Asset Management, exiting entirely with an estimated $17.1M sold.

  • 200 institutional investors held Heron Therapeutics (HRTX) as of Q4 2021, up from 197 in Q3 2021.
  • Funds reported $1.07B of Heron Therapeutics stock for Q4 2021, down 7.6% quarter-over-quarter.
  • 32 funds opened new Heron Therapeutics positions in Q4 2021 and 26 closed out, a net change of +6 holders.
  • The largest Heron Therapeutics buyer in Q4 2021 was UBS O'Connor, an estimated $16.8M added.
  • The largest Heron Therapeutics seller in Q4 2021 was Point72 Asset Management, an estimated $17.1M sold.

Based on aggregated 13F filings for Q4 2021.